261 related articles for article (PubMed ID: 25662368)
1. Anabolic effects of PTH and the 'anabolic window'.
Pazianas M
Trends Endocrinol Metab; 2015 Mar; 26(3):111-3. PubMed ID: 25662368
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant human parathyroid hormone--new perspectives for anabolic therapy of osteoporosis].
Miazgowski T; Stefański A
Pol Arch Med Wewn; 2004 Oct; 112(4):1249-54. PubMed ID: 15773439
[No Abstract] [Full Text] [Related]
4. Molecular and pharmacological aspects of existing and experimental bone anabolic therapies.
Chattopadhyay N
Curr Mol Pharmacol; 2012 Jun; 5(2):125-6. PubMed ID: 21787294
[No Abstract] [Full Text] [Related]
5. Anabolic effects of intermittent PTH on osteoblasts.
Greenfield EM
Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
[TBL] [Abstract][Full Text] [Related]
6. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone - a bone anabolic and catabolic agent.
Poole KE; Reeve J
Curr Opin Pharmacol; 2005 Dec; 5(6):612-7. PubMed ID: 16181808
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic targets for osteoporosis: beyond denosumab.
Lim V; Clarke BL
Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
[TBL] [Abstract][Full Text] [Related]
9. Effects of bone anabolic agents on bone ultrastructure.
Cortet B
Osteoporos Int; 2009 Jun; 20(6):1097-100. PubMed ID: 19340503
[No Abstract] [Full Text] [Related]
10. Parathyroid hormone as an anabolic therapy for women and men.
Bilezikian JP; Rubin MR; Finkelstein JS
J Endocrinol Invest; 2005; 28(8 Suppl):41-9. PubMed ID: 16329201
[TBL] [Abstract][Full Text] [Related]
11. The rhPTH (1-34), but not elcatonin, increases bone anabolic efficacy in postmenopausal women with osteoporosis.
Zhang L; Yang M; Liu D; Guo C; Li L; Yang G
Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):361-6. PubMed ID: 22639400
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis.
Augustine M; Horwitz MJ
Curr Osteoporos Rep; 2013 Dec; 11(4):400-6. PubMed ID: 24078470
[TBL] [Abstract][Full Text] [Related]
13. The use of PTH in the treatment of osteoporosis.
Borba VZ; Mañas NC
Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):213-9. PubMed ID: 20485911
[TBL] [Abstract][Full Text] [Related]
14. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
15. Combination anabolic and antiresorptive therapy for osteoporosis.
Cusano NE; Bilezikian JP
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):643-54. PubMed ID: 22877434
[TBL] [Abstract][Full Text] [Related]
16. Protein malnutrition attenuates bone anabolic response to PTH in female rats.
Ammann P; Zacchetti G; Gasser JA; Lavet C; Rizzoli R
Endocrinology; 2015 Feb; 156(2):419-28. PubMed ID: 25396268
[TBL] [Abstract][Full Text] [Related]
17. [Parathyroid hormone -- its mechanisms of action and issues on clinical application].
Okazaki R
Clin Calcium; 2005 May; 15(5):845-51. PubMed ID: 15876749
[TBL] [Abstract][Full Text] [Related]
18. Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone.
Koh AJ; Demiralp B; Neiva KG; Hooten J; Nohutcu RM; Shim H; Datta NS; Taichman RS; McCauley LK
Endocrinology; 2005 Nov; 146(11):4584-96. PubMed ID: 16081645
[TBL] [Abstract][Full Text] [Related]
19. ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans.
John MR; Widler L; Gamse R; Buhl T; Seuwen K; Breitenstein W; Bruin GJ; Belleli R; Klickstein LB; Kneissel M
Bone; 2011 Aug; 49(2):233-41. PubMed ID: 21514409
[TBL] [Abstract][Full Text] [Related]
20. New anabolic therapies in osteoporosis.
Rubin MR; Bilezikian JP
Endocrinol Metab Clin North Am; 2003 Mar; 32(1):285-307. PubMed ID: 12699304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
